Purified Inactivated Japanese Encephalitis Vaccine

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This study evaluates the immunogenicity and safety of a purified inactivated JE vaccine compared to a commercialized JE vaccine. In this phase III, randomized, blind trial, infants at 6-23 months of age were randomly assigned to three groups to receive experimental vaccine or control vaccine with two different vaccination schedule respectively.
Epistemonikos ID: 057020ab3976c67717e67402e238c7adbe508667
First added on: Mar 23, 2020